These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1503094)

  • 21. Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases.
    Palomera L; Domingo JM; Sola C; Azaceta G; Calvo MT; Gutierrez M
    Haematologica; 2002 Jan; 87(1):107-8. PubMed ID: 11801472
    [No Abstract]   [Full Text] [Related]  

  • 22. The clinical evaluation of hairy cell leukemia.
    Demeter J; Porzsolt F
    Blood; 1992 Apr; 79(8):2171-3. PubMed ID: 1510754
    [No Abstract]   [Full Text] [Related]  

  • 23. Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy.
    Ehmann WC; Silber R
    Am J Med; 1986 Jun; 80(6):1111-4. PubMed ID: 3728508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of hairy cell leukemia with increasing doses of recombinant alpha A interferon.
    Holmes R; Schwarz MA; Whiteside MG; Firkin FC
    Aust N Z J Med; 1988 Jun; 18(4):557-62. PubMed ID: 3196242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hairy cell leukemia: bone marrow changes following splenectomy and alpha-interferon therapy.
    Pangalis GA; Kittas C; Viniou N; Kokkinou S; Variamis H; Paizis P; Melanthiou F; Fessas P
    Leukemia; 1987 Apr; 1(4):343-6. PubMed ID: 3669761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Splenectomy following complete response to alpha interferon (IFN) therapy in patients with hairy cell leukemia (HCL): results of the HCL88 protocol. Italian Cooperative Group for the Study of Hairy Cell Leukemia (ICGHCL).
    Damasio EE; Frassoldati A
    Leuk Lymphoma; 1994; 14 Suppl 1():95-8. PubMed ID: 7820061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.
    Jehn U; Bartl R; Dietzfelbinger H; Haferlach T; Heinemann V
    Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of interferon-alpha administration after 2-deoxycoformycin in the treatment of hairy cell leukemia patients.
    Marotta G; Frassoldati A; Zinzani P; Annino L; Brugiatelli M; Ambrosetti A; Lenoci M; Federico M; Foa R; Lauria F;
    Eur J Haematol; 2006 Aug; 77(2):109-13. PubMed ID: 16856905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon alpha in the treatment of hairy cell leukemia.
    Castaigne S; Sigaux F; Cantell K; Falcoff E; Boiron M; Flandrin G; Degos L
    Cancer; 1986 Apr; 57(8 Suppl):1681-4. PubMed ID: 3948138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Splenectomy in the treatment of hairy cell leukemia].
    Iudin MIa; Iavorkovskiĭ LL; Liepi'nsh MA
    Vestn Khir Im I I Grek; 1989 May; 142(5):39-43. PubMed ID: 2800213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia.
    Golomb HM; Fefer A; Golde DW; Ozer H; Portlock C; Silber R; Rappeport J; Ratain MJ; Thompson J; Bonnem EM
    Semin Oncol; 1987 Jun; 14(2 Suppl 2):13-7. PubMed ID: 3589701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose interferon alfa-2b in the treatment of hairy cell leukemia.
    Moormeier JA; Ratain MJ; Westbrook CA; Vardiman JW; Daly KM; Golomb HM
    J Natl Cancer Inst; 1989 Aug; 81(15):1172-4. PubMed ID: 2746669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of treating 53 hairy cell leukemia patients with alpha-interferon.
    Flandrin G; Castaigne S; Sigaux F; Degos L
    Leukemia; 1987 Apr; 1(4):326-8. PubMed ID: 3669755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The degree of bone marrow infiltration in patients with hairy cell leukemia treated with splenectomy compatible with long-term hematological remission.
    Zák P; Chrobák L; Dedic K
    Neoplasma; 2001; 48(1):72-5. PubMed ID: 11327542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hairy cell leukemia: prognosis and treatment].
    Quaresima M; Iacobelli S; Tempera S; Frattarelli N; Bizzoni L; Anaclerico B; Matturro A; Cucchi F; Tafuri A; Pulsoni A
    Clin Ter; 2006; 157(2):105-9. PubMed ID: 16817498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results in hairy-cell leukemia patients treated with alpha-interferon: predictive prognostic factors.
    Zinzani PL; Lauria F; Raspadori D; Rondelli D; Benfenati D; Pileri S; Sabattini E; Tura S
    Eur J Haematol; 1992 Sep; 49(3):133-7. PubMed ID: 1446727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early response to alpha interferon in a patient affected by hairy cell leukemia.
    Di Raimondo F; Murolo D; Milone G; Cacciola E; Giustolisi R
    Haematologica; 1992; 77(4):355-6. PubMed ID: 1427445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategy for the treatment of hairy cell leukemia.
    Porzsolt F; Raghavachar A; Digel W; Raghavachar A; Bartram CR; Heimpel H
    Leukemia; 1987 Apr; 1(4):334-7. PubMed ID: 3669758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skeletal complications in hairy cell leukemia: diagnosis and therapy.
    Lembersky BC; Ratain MJ; Golomb HM
    J Clin Oncol; 1988 Aug; 6(8):1280-4. PubMed ID: 3411340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Improvement with interferon-alpha therapy and splenectomy in hairy cell leukemia of European-American type].
    Yasuyama M; Kawauchi K; Sugiyama H; Mori H; Enomoto Y; Watanabe Y; Machii T; Kitani T
    Rinsho Ketsueki; 1992 Mar; 33(3):365-70. PubMed ID: 1578641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.